Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert James Mayer, M.D.

Co-Author

This page shows the publications co-authored by Robert Mayer and Marc Garnick.
Connection Strength

0.144
  1. Acute renal failure associated with neoplastic disease and its treatment. Semin Oncol. 1978 Jun; 5(2):155-65.
    View in: PubMed
    Score: 0.048
  2. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983 Sep; 67(9):773-7.
    View in: PubMed
    Score: 0.017
  3. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol. 1983 May; 1(5):337-44.
    View in: PubMed
    Score: 0.017
  4. Acute leukemia after radiotherapy in a patient with Turcot's syndrome. Impaired colony formation in skin fibroblast cultures after irradiation. Am J Med. 1983 Feb; 74(2):343-8.
    View in: PubMed
    Score: 0.016
  5. Testicular self-examination. N Engl J Med. 1980 Jan 31; 302(5):297.
    View in: PubMed
    Score: 0.013
  6. Phase I trial of bruceantin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1929-32.
    View in: PubMed
    Score: 0.013
  7. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer. 1978 Sep; 42(3 Suppl):1428-33.
    View in: PubMed
    Score: 0.012
  8. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):17-20.
    View in: PubMed
    Score: 0.004
  9. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med. 1980 Mar; 68(3):370-6.
    View in: PubMed
    Score: 0.003
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.